Yves Réguerre

Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients

Nöel Milpied, B. Vasseur, Nathalie Parquet et al. · Annals of Oncology · 2000 · 376 citations · Full text

Life Sciences, Hematology, Immunology +16

Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network

Aurélie Caye, Marion Strullu, Fabien Guidez et al. · Nature Genetics · 2015 · 191 citations

Medicine, Genetics, Oncology +16

Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial

Frédéric Millot, André Baruchel, Joëlle Guilhot et al. · Journal of Clinical Oncology · 2011 · 165 citations

Pharmacy, Hematology, Pharmacotherapy +9

Chimaeric anti‐CD20 monoclonal antibody (rituximab) in post‐transplant B‐lymphoproliferative disorder following stem cell transplantation in children

Albert Faye, Pierre Quartier, Yves Réguerre et al. · British Journal of Haematology · 2001 · 139 citations

Life Sciences, Hematology, Immunology +15

Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age

Charlotte Rigaud, Mohamed Barkaoui, Caroline Thomas et al. · British Journal of Haematology · 2016 · 129 citations

Medicine, Pathology, Pharmacology +8